e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Madrigal Pharmaceuticals, Inc. - Common Stock (NQ:MDGL)

487.12 -0.20 (-0.04%)

Streaming Delayed Price Updated: 1:54 PM EST, Feb 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Madrigal Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

12 Health Care Stocks Moving In Monday's Intraday Session ↗

December 19, 2022

Via Benzinga

Why Madrigal Pharmaceuticals Stock Is Crushing It Today ↗

December 19, 2022

The company reported stellar late-stage clinical trial results for its experimental NASH (nonalcoholic steatohepatitis) drug.

Via The Motley Fool

Madrigal Pharmaceuticals, Cerevel Therapeutics And Some Other Big Stocks Moving Higher On Monday ↗

December 19, 2022

U.S. stocks traded mixed, with the Nasdaq Composite dropping around 90 points on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Tesla's Bouncing, but This Nasdaq Stock Tripled Monday Morning ↗

December 19, 2022

Good news can come in different forms.

Via The Motley Fool

Why Is Viking Therapeutics (VKTX) Stock Up 67% Today? ↗

December 19, 2022

Viking Therapeutics (VKTX) stock is taking off on Monday with heavy trading without any news from the biopharmaceutical company.

Via InvestorPlace

Madrigal Shares Skyrocket After Successful NASH Study ↗

December 19, 2022

Via Benzinga

Analysts Believe Madrigal's Resmetirom Shows Impressive Overall Profile In Liver Fibrosis ↗

June 27, 2022

Via Benzinga

Recap: Madrigal Pharmaceuticals Q1 Earnings ↗

May 09, 2022

Madrigal Pharmaceuticals (NASDAQ:MDGL) reported its Q1 earnings results on Monday, May 9, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

AJRD Stock Alert: What to Know as L3Harris Technologies Acquires Aerojet Rocketdyne ↗

December 19, 2022

Aerojet Rocketdyne (AJRD) stock is on the move today as investors react to a $4.7 billion deal with L3Harris Technologies (LHX).

Via InvestorPlace

Madrigal Pharmaceuticals Stock Is Up 200% In One Day, Here's Why

December 19, 2022

Madrigal Pharmaceuticals announced positive results for a major clinical trial and shares are up more than 200% because of it.

Via MarketBeat

Why Viking Therapeutics Stock Is Moving Alongside Madrigal Pharmaceuticals Shares Today ↗

December 19, 2022

Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Monday, in sympathy with Madrigal Pharmaceuticals Inc (NASDAQ: MDGL), which announced a suc

Via Benzinga

Why Is Madrigal Pharmaceuticals (MDGL) Stock Up 216% Today? ↗

December 19, 2022

Madrigal Pharmaceuticals (MDGL) stock is rocketing higher on Monday after sharing positive results from its NASH treatment.

Via InvestorPlace

Madrigal Pharma Stock Triples After Knocking NASH Study Out Of The Park ↗

December 19, 2022

The company hit both of its goals in a Phase 3 study of a pill for the liver disease.

Via Investor's Business Daily

Madrigal Pharma's Kidney Disease Candidate Improves Liver, Cardiovascular Health ↗

January 31, 2022

Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) has

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 19, 2022

Via Benzinga

Tesla, Amazon, Madrigal Pharma, Pfizer, Synaptogenix: Why These 5 Stocks Are Drawing Investors' Attention Today ↗

December 18, 2022

Major Wall Street indices had closed in the red on Friday in the wake of a continued sell-off following the hawkish stance asserted by the Federal Reserve. Friday witnessed volatile trading as a large...

Via Benzinga

2 Healthcare Stocks Poised to Rocket Higher in the 4th Quarter ↗

November 06, 2022

These two healthcare stocks could deliver market-crushing gains by year's end.

Via The Motley Fool

Madrigal Pharmaceuticals: Q3 Earnings Insights ↗

November 03, 2022

Madrigal Pharmaceuticals (NASDAQ:MDGL) reported its Q3 earnings results on Thursday, November 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

October 28, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

October 25, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

October 17, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 8, 2022 ↗

July 08, 2022

Via Benzinga

Bear Market Rally Lifts HealthCare Stocks Off Bottom ↗

June 22, 2022

Clearly we are in a biotech bear market with both diagnostics and vaccine revenues stalled. If gene editing stocks cannot offer breakthrough clinical news then stick with large cap biopharma.

Via Talk Markets

Madrigal Announces Debt Funding Of $250M To Back Potential US Resmetirom Launch ↗

May 09, 2022

Via Benzinga

Tough Slogging Ahead for Investors, Diversification is Important ↗

March 07, 2022

Speculative small/mid-cap biotech stocks hit new lows this past week with the XBI at a “triple bottom” about the $84 level only 10 points above the March 2020 lows.

Via Talk Markets

Madrigal Pharmaceuticals: A "Best in Class" Biotech Buy ↗

February 17, 2022

One of the few broadly positive binary events in biotechnology of late, Madrigal’s best-in-class NASH compound is well on its way with de-risked, late-stage clinical results.

Via Talk Markets

Bear Market Bets In Biotech ↗

February 07, 2022

Taken together, the SPDR S&P Biotech ETF easily broke below the long-term 200-week support for the first time since the pandemic originally hit the markets in March of 2020.

Via Talk Markets

Earnings Scheduled For May 9, 2022 ↗

May 09, 2022

Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 03, 2022

Gainers SOC Telemed (NASDAQ:TLMD) shares increased by 333.5% to $2.79 during Thursday's regular session. Trading volume for this security as of 12:30 EST is 19.4...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 31, 2022

Gainers Madrigal Pharmaceuticals (NASDAQ:MDGL) shares rose 14.9% to $64.8 during Monday's pre-market session. The market value of their outstanding shares is at $1.1...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy